Total assets grew to $69.9 billion in Q2 2026 from $59.5 billion in Q1 2024, with equity of $11.2 billion and a conservative debt-to-equity ratio of 0.27, though legacy LTC and social inflation risks warrant monitoring.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Total Assets | 69.87B | 69.44B | 60.81B | 59.56B | 55.79B | 61.69B | 60.19B | 56.87B | 52.92B | 52.73B | 51.39B | 50.98B | 51.7B | 51.95B | 53.45B | 49.92B | 48.96B | 55.77B | 52.21B | 57.64B | 61.49B | 58.79B | 62.5B | 68.5B | 61.73B | 65.97B | 62.07B | 61.22B | 62.36B | 61.27B | 60.73B |
| Asset Growth % | 30.7% | 14.19% | 2.1% | 6.75% | -9.55% | 2.48% | 5.85% | 7.46% | 0.36% | 2.6% | 0.81% | -1.4% | -0.47% | -2.82% | 7.08% | 1.97% | -12.22% | 6.83% | -9.42% | -6.26% | 4.6% | -5.94% | -8.76% | 10.97% | -6.42% | 6.28% | 1.39% | -1.83% | 1.78% | 0.88% | 1.39% |
| Total Investment Assets | 4M | 50.45B | 47.48B | 46.56B | 43.18B | 50.33B | 50.29B | 47.74B | 44.49B | 46.87B | 45.42B | 44.7B | 46.26B | 46.29B | 47.95B | 44.79B | 43.1B | 42.42B | 35.39B | 42.24B | 44.6B | 38.72B | 38.14B | 37.75B | 34.58B | 34.88B | 34.4B | 34.69B | 36.51B | 40.13B | 40.29B |
| Long-Term Investments | 187.67B | 46.74B | 47.48B | 46.56B | 43.18B | 50.33B | 50.29B | 47.74B | 44.49B | 46.87B | 45.42B | 44.7B | 46.26B | 46.29B | 47.95B | 44.79B | 43.1B | 42.42B | 35.39B | 42.24B | 44.6B | 38.15B | 37.65B | 36.74B | 33.95B | 34.24B | 33.79B | 34.21B | 36.08B | 35.25B | 34.43B |
| Short-Term Investments | 1.72B | 3.71B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.24B | 5.86B | 7.54B | 7.01B | 3.74B | 4.72B | 3.35B | 4.04B | 4.88B | 5.85B |
| Total Current Assets | 2.06B | 14.73B | 4.14B | 3.79B | 3.63B | 3.48B | 3.03B | 2.69B | 2.63B | 2.65B | 2.48B | 2.46B | 2.13B | 2.17B | 2.04B | 1.69B | 1.63B | 8.38B | 9.3B | 10.29B | 11.67B | 58.44B | 62.1B | 68.03B | 61.19B | 65.26B | 61.03B | 60.15B | 61.17B | 59.9B | 59.67B |
| Cash & Equivalents | 339M | 425M | 472M | 345M | 475M | 536M | 419M | 242M | 310M | 355M | 271M | 387M | 190M | 195M | 156M | 75M | 77M | 140M | 85M | 94M | 84M | 96M | 95M | 139M | 126M | 142M | 163M | 153M | 217M | 383M | 257.1M |
| Receivables | 35.98B | 10.6B | 3.67B | 3.44B | 3.16B | 2.94B | 2.61B | 2.45B | 2.32B | 2.29B | 2.21B | 2.08B | 1.94B | 1.98B | 1.88B | 1.61B | 1.56B | 8.24B | 9.21B | 10.2B | 11.59B | 14.07B | 17.54B | 2.69B | 15.51B | 3.83B | 15M | 2.21B | 251M | 18M | 133.8M |
| Other Current Assets | -4.2B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 19.63B | 25.42B | 41.37B | 38.55B | 60.77B | 56.13B | 54.43B | 56.66B | 54.62B | 53.43B |
| Goodwill & Intangibles | 3.57B | 1.13B | 222M | 224M | 144M | 215M | 217M | 147M | 146M | 148M | 145M | 231M | 237M | 155M | 267M | 139M | 141M | 141M | 141M | 142M | 142M | 146M | 162M | 162M | 174M | 265M | 317M | 328M | 368M | 620M | 417.7M |
| Goodwill | 147M | 148M | 145M | 146M | 144M | 148M | 148M | 147M | 146M | 148M | 145M | 150M | 152M | 155M | 154M | 123M | 0 | 141M | 141M | 142M | 142M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 986M | 77M | 78M | 0 | 67M | 69M | 0 | 0 | 0 | 0 | 81M | 85M | 0 | 113M | 16M | 141M | 0 | 0 | 0 | 0 | 146M | 162M | 162M | 174M | 265M | 317M | 328M | 368M | 620M | 417.7M |
| PP&E (Net) | 291M | 282M | 453M | 393M | 381M | 401M | 451M | 502M | 324M | 326M | 310M | 343M | 295M | 304M | 326M | 309M | 333M | 360M | 393M | 378M | 277M | 197M | 235M | 314M | 369M | 444M | 716M | 746M | 824M | 747M | 645.4M |
| Other Assets | -47.31B | 5.98B | 7.29B | 7.32B | 7B | 6.61B | 5.52B | 5.15B | 4.75B | 2.18B | 2.08B | 2.22B | 1.76B | 2.06B | 1.71B | 1.79B | 2.4B | 2.7B | 3.02B | 2.53B | 2.8B | -38.15B | -37.65B | -36.74B | -33.95B | -34.24B | -33.79B | -34.21B | -36.08B | -35.25B | -34.43B |
| Total Liabilities | 58.69B | 57.82B | 50.3B | 49.67B | 47.25B | 48.88B | 47.49B | 44.65B | 41.7B | 40.48B | 39.42B | 39.22B | 38.91B | 39.27B | 41.12B | 38.41B | 37.41B | 44.58B | 44.87B | 47.05B | 51.33B | 49.55B | 53.02B | 59.3B | 52.07B | 57.38B | 52.2B | 52.09B | 53B | 52.96B | 53.67B |
| Total Debt | 2.97B | 2.97B | 3.21B | 3.25B | 3B | 3.03B | 3.11B | 3.05B | 2.68B | 2.86B | 2.71B | 2.56B | 2.56B | 2.56B | 2.57B | 2.61B | 2.65B | 2.3B | 2.06B | 2.16B | 2.16B | 1.69B | 2.26B | 1.9B | 2.29B | 2.57B | 2.73B | 2.88B | 3.16B | 2.9B | 2.76B |
| Net Debt | 2.63B | 2.55B | 2.74B | 2.9B | 2.53B | 2.49B | 2.69B | 2.81B | 2.37B | 2.5B | 2.44B | 2.17B | 2.37B | 2.37B | 2.41B | 2.53B | 2.57B | 2.16B | 1.97B | 2.06B | 2.07B | 1.59B | 2.16B | 1.76B | 2.17B | 2.42B | 2.57B | 2.73B | 2.94B | 2.51B | 2.51B |
| Long-Term Debt | 2.97B | 2.97B | 2.97B | 2.48B | 2.54B | 2.78B | 2.78B | 2.68B | 2.68B | 2.71B | 2.71B | 2.21B | 2.56B | 2.01B | 2.56B | 2.52B | 2.25B | 2.3B | 2.06B | 1.81B | 2.16B | 1.44B | 1.73B | 1.64B | 1.87B | 2.24B | 2.73B | 2.88B | 3.16B | 2.9B | 2.76B |
| Short-Term Debt | 0 | 0 | 43M | 586M | 243M | 42M | 44M | 38M | 0 | 150M | 0 | 350M | 0 | 549M | 13M | 83M | 400M | 0 | 0 | 350M | 0 | 252M | 531M | 263M | 420M | 329M | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | 3.8B | 38.37B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48.4B | 51.51B | 57.91B | 50.46B | 55.03B | 49.69B | 49.4B | 50.04B | 50.06B | 50.91B |
| Accounts Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.64B | 0 | 3.43B | 2.76B | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 3.8B | 7.63B | 7.35B | 6.93B | 6.37B | 5.76B | 5.12B | 4.58B | 4.18B | 4.03B | 3.76B | 3.67B | 3.59B | 3.72B | 3.61B | 3.25B | 3.2B | 3.27B | 3.41B | 3.6B | 3.78B | 0 | 0 | 0 | 29M | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 30.74B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 31.12B | 31.87B | -3.44B | -2.99B | 51.98B | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 45.42B | 12.34B | 42.23B | 42.05B | 39.56B | 40.88B | 39.77B | 37.43B | 35.43B | 37.35B | 36.14B | 36.63B | 35.52B | 36.52B | 37.49B | 35.1B | 34.48B | 41.83B | 42.33B | 44.39B | 48.02B | 0 | 0 | 0 | -34M | 329M | -2.73B | -2.88B | -3.16B | -2.9B | -2.76B |
| Total Equity | 11.19B | 11.62B | 10.51B | 9.89B | 8.55B | 12.81B | 12.71B | 12.21B | 11.22B | 12.24B | 11.97B | 11.76B | 12.79B | 12.67B | 12.34B | 11.51B | 11.55B | 11.2B | 7.34B | 10.59B | 10.16B | 9.24B | 9.48B | 9.21B | 9.66B | 8.59B | 9.86B | 9.13B | 9.36B | 8.31B | 7.06B |
| Equity Growth % | 26.33% | 10.54% | 6.27% | 15.73% | -33.27% | 0.8% | 4.03% | 8.9% | -8.39% | 2.3% | 1.81% | -8.12% | 0.95% | 2.75% | 7.17% | -0.35% | 3.16% | 52.55% | -30.67% | 4.18% | 9.96% | -2.54% | 2.98% | -4.65% | 12.41% | -12.91% | 8% | -2.44% | 12.66% | 17.69% | 4.81% |
| Shareholders Equity | 11.19B | 11.62B | 10.51B | 9.89B | 8.55B | 12.81B | 12.71B | 12.21B | 11.22B | 12.24B | 11.97B | 11.76B | 12.79B | 12.67B | 12.34B | 11.51B | 10.98B | 10.69B | 6.92B | 10.2B | 9.83B | 8.95B | 9.21B | 8.95B | 9.4B | 8.37B | 9.65B | 8.94B | 9.16B | 8.31B | 7.06B |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 570M | 506M | 420M | 385M | 335M | 291M | 275M | 256M | 256M | 224M | 217M | 195M | 204M | 0 | 0 |
| Retained Earnings | 9.64B | 9.91B | 9.69B | 9.76B | 9.34B | 9.66B | 9.08B | 9.35B | 9.28B | 9.41B | 9.36B | 9.31B | 9.64B | 9.49B | 8.77B | 8.31B | 7.88B | 7.26B | 6.84B | 7.29B | 6.49B | 5.62B | 5.6B | 5.16B | 6.59B | 6.68B | 8.33B | 7.11B | 7.26B | 6.98B | 6.02B |
| Common Stock | 683M | 683M | 683M | 683M | 683M | 683M | 683M | 683M | 683M | 683M | 683M | 683M | 683M | 683M | 683M | 683M | 683M | 683M | 683M | 683M | 683M | 645M | 645M | 565M | 565M | 565M | 464M | 464M | 464M | 155M | 154.6M |
| Accumulated OCI | -1.22B | -1.1B | -1.99B | -2.67B | -3.6B | 320M | 803M | 51M | -878M | 32M | -173M | -315M | 400M | 442M | 831M | 480M | 326M | -325M | -3.92B | 103M | 549M | 359M | 650M | 841M | 604M | 226M | 873M | 1.19B | 1.06B | 589M | 298.7M |
| Return on Equity (ROE) | 11.99% | 11.55% | 9.4% | 13.07% | 6.39% | 9.28% | 5.54% | 8.54% | 6.93% | 7.43% | 7.24% | 3.9% | 5.43% | 7.49% | 5.27% | 5.31% | 6.07% | 4.52% | -3.34% | 8.2% | 11.42% | 2.82% | 4.55% | -15.02% | 1.79% | -17.39% | 12.44% | -1.86% | 2.58% | 12.57% | 13.99% |
| Return on Assets (ROA) | 1.94% | 1.96% | 1.59% | 2.09% | 1.16% | 1.94% | 1.18% | 1.82% | 1.54% | 1.73% | 1.68% | 0.93% | 1.33% | 1.78% | 1.21% | 1.24% | 1.32% | 0.78% | -0.54% | 1.43% | 1.84% | 0.44% | 0.65% | -2.18% | 0.26% | -2.51% | 1.92% | -0.28% | 0.37% | 1.58% | 1.6% |
| Equity / Assets | 16.01% | 16.73% | 17.29% | 16.61% | 15.32% | 20.76% | 21.11% | 21.48% | 21.2% | 23.22% | 23.29% | 23.06% | 24.75% | 24.4% | 23.08% | 23.06% | 23.59% | 20.07% | 14.06% | 18.37% | 16.53% | 15.72% | 15.17% | 13.44% | 15.64% | 13.02% | 15.89% | 14.92% | 15.01% | 13.56% | 11.62% |
| Debt / Equity | 0.27x | 0.26x | 0.31x | 0.33x | 0.35x | 0.24x | 0.24x | 0.25x | 0.24x | 0.23x | 0.23x | 0.22x | 0.20x | 0.20x | 0.21x | 0.23x | 0.23x | 0.21x | 0.28x | 0.20x | 0.21x | 0.18x | 0.24x | 0.21x | 0.24x | 0.30x | 0.28x | 0.32x | 0.34x | 0.35x | 0.39x |
| Book Value per Share | 41.17 | 42.68 | 38.55 | 36.34 | 31.37 | 46.95 | 46.58 | 44.84 | 41.16 | 45.00 | 44.15 | 43.43 | 47.28 | 46.91 | 45.72 | 42.69 | 42.86 | 41.61 | 27.24 | 38.95 | 38.74 | 36.10 | 37.04 | 40.59 | 42.66 | 42.77 | 53.45 | 48.04 | 50.41 | 44.76 | 38.04 |
| Tangible BV per Share | 40.63 | 38.51 | 37.74 | 35.52 | 30.84 | 46.17 | 45.78 | 44.30 | 40.63 | 44.45 | 43.61 | 42.57 | 46.41 | 46.33 | 44.73 | 42.18 | 42.33 | 41.08 | 26.72 | 38.43 | 38.20 | 35.53 | 36.41 | 39.87 | 41.89 | 41.45 | 51.74 | 46.32 | 48.42 | 41.42 | 35.79 |
Nuclear verdicts and reserve adequacy
Total assets grew to $69.9B in Q2 2026 from $59.5B in Q1 2024, as per reported figures, indicating steady balance sheet expansion driven by premium growth and retained earnings.
The sequential increase in total assets from $68.6B in Q1 2026 to $69.9B in Q2 2026, alongside a rise in equity from $10.9B to $11.2B, suggests ongoing capital generation. This growth appears consistent with the hard market conditions, where premium rate increases are boosting written premiums and, consequently, invested assets. However, the pace of expansion has moderated compared to the earlier period, reflecting a maturing pricing cycle.
Investment portfolio remains stable at $1.0B, as reported, with no unrealized loss data available; however, the low combined ratio suggests investment income is providing a buffer, based on reported figures.
The reported investment portfolio value of $1.0B is unusually low relative to total assets, likely indicating a data limitation rather than actual portfolio size. Given the company's P&C focus, the investment portfolio is typically the largest asset, and the stable combined ratio around 88-90% implies that investment income is contributing positively to overall profitability. The absence of investment yield data limits deeper analysis, but the consistency in combined ratios suggests investment returns are stable.
Loss ratio improved to 65.9% in Q2 2026 from 70.2% a year earlier, as per reported figures, suggesting favorable prior-year reserve development that may be flattering current earnings.
The year-over-year improvement in the loss ratio from 70.2% in Q2 2025 to 65.9% in Q2 2026, despite stable claims payments around $2.5B per quarter, indicates that reserve releases are contributing to underwriting profitability. This trend, also noted in the income statement analysis, suggests that past underwriting was conservative. However, investors should monitor whether such favorable development can persist, as social inflation and nuclear verdicts could necessitate adverse reserve adjustments in the future.
Equity rose to $11.2B in Q2 2026 from $10.7B a year earlier, as reported, while debt-to-equity remains minimal at 0.26%, indicating a strong capital position.
The increase in equity, coupled with the extremely low financial leverage, suggests that CNA maintains a fortress-like balance sheet. This capital strength provides ample capacity for dividend payments, including special dividends, and potential strategic actions. The low debt levels also imply significant untapped borrowing capacity, which could be used to weather severe underwriting losses or fund opportunistic acquisitions, though management's conservative approach under Loews may prioritize capital preservation.
Claims payments have remained stable at approximately $2.5B per quarter over the past year, as per reported figures, while operating cash flow consistently exceeds net income, indicating robust liquidity.
The stability in claims payments, despite inflationary concerns, suggests that CNA's liquidity position is adequate to meet its obligations. The cash flow analysis indicates that operating cash flow has been consistently strong, with an OCF/NI ratio around 2.0, implying that earnings are well-backed by cash. This liquidity profile, combined with a diversified investment portfolio, supports the company's ability to pay claims even in adverse scenarios, though the lack of detailed cash and liquid asset data limits a more precise assessment.
The Life & Group run-off segment and rising nuclear verdicts may pose hidden reserve risks, as per industry trends, potentially straining future balance sheet strength.
While the core P&C operations appear healthy, the legacy long-term care (LTC) liabilities in the Life & Group segment remain a potential source of adverse reserve development. Additionally, the increasing frequency of nuclear verdicts in casualty lines could require reserve strengthening, particularly in umbrella and general liability. These factors, combined with the lack of forward guidance, suggest that the current balance sheet strength may be tested in future periods, warranting close monitoring of reserve adequacy and loss cost trends.
Quick answers to the most common questions about buying CNA stock.
As of 2025, CNA Financial Corporation (CNA) had total assets of $69.44B including $14.73B in current assets.
CNA Financial Corporation (CNA) carries total debt of $2.97B, offset by $4.13B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
CNA Financial Corporation (CNA) has total shareholders' equity (book value) of $11.62B ($42.68 book value per share). Book value represents the net worth of the company belonging to common stock holders.
CNA Financial Corporation (CNA) reported a current ratio of 0.38x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.